What are the first‑line treatment regimens for common sexually transmitted infections such as chlamydia, gonorrhea, syphilis, trichomoniasis, genital herpes, and HPV‑related genital warts?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 20, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

First-Line Treatment for Common Sexually Transmitted Infections

For chlamydia, use doxycycline 100 mg orally twice daily for 7 days as first-line therapy; for gonorrhea, use ceftriaxone 500 mg IM (≥150 kg body weight) or 250 mg IM (<150 kg); for syphilis, use penicillin G benzathine 2.4 million units IM; for trichomoniasis, use metronidazole 500 mg orally twice daily for 7 days; for genital herpes, use antivirals for symptomatic episodes; and for genital warts, use patient-applied imiquimod or provider-applied cryotherapy.

Chlamydia (Chlamydia trachomatis)

Recommended First-Line Treatment:

  • Doxycycline 100 mg orally twice daily for 7 days 1
  • Alternative: Azithromycin 1 g orally as a single dose 2, 3, 4, 5

Key Clinical Points:

  • Doxycycline is now preferred over azithromycin due to superior efficacy and concerns about Mycoplasma genitalium resistance to macrolides 1
  • Azithromycin remains useful when compliance with 7-day regimens is questionable or for directly observed therapy 2, 4, 5
  • Both regimens have cure rates of 97-98% in clinical trials 5
  • Patients must abstain from sexual intercourse for 7 days after single-dose therapy or until completion of 7-day regimen 2, 4

Additional Alternatives:

  • Levofloxacin 500 mg orally once daily for 7 days 3, 4, 5
  • Ofloxacin 300 mg orally twice daily for 7 days 2, 4, 5
  • Erythromycin base 500 mg orally four times daily for 7 days (less effective, more GI side effects) 2, 4, 5

Important Caveats:

  • Test-of-cure for rectal chlamydia if treated with azithromycin 1
  • Rescreen all women approximately 3 months after treatment due to high reinfection rates 4, 5
  • Coinfection with gonorrhea is common; treat presumptively for both when gonorrhea is diagnosed 2, 6

Gonorrhea (Neisseria gonorrhoeae)

Recommended First-Line Treatment:

  • Ceftriaxone 500 mg IM as a single dose for patients weighing ≥150 kg 1
  • Ceftriaxone 250 mg IM as a single dose for patients weighing <150 kg 1
  • PLUS treatment for chlamydia (doxycycline 100 mg orally twice daily for 7 days) due to high coinfection rates 7, 1

Key Clinical Points:

  • Ceftriaxone monotherapy is now recommended (no longer requires dual therapy with azithromycin) 1
  • Weight-based dosing reflects updated 2021 CDC guidelines 1
  • Increasing antimicrobial resistance limits oral treatment options 8, 9

Pharyngeal Gonorrhea:

  • Same ceftriaxone dosing as above 2
  • Test-of-cure is mandatory for all pharyngeal gonorrhea cases 1
  • Pharyngeal infections are more difficult to eradicate than urogenital infections 2

Alternative Regimens (if ceftriaxone unavailable):

  • Cefixime 800 mg orally as a single dose (less effective than ceftriaxone) 2
  • Spectinomycin 2 g IM (not available in US; useful for cephalosporin allergy; ineffective for pharyngeal infection) 2

Critical Management Points:

  • Patients should abstain from sexual intercourse until therapy completed and partners treated 2
  • Partner notification and treatment within 60 days of symptom onset 2
  • Fluoroquinolones (ciprofloxacin, ofloxacin) are no longer recommended due to widespread resistance 2, 8

Syphilis (Treponema pallidum)

Primary, Secondary, or Early Latent Syphilis (<1 year duration):

  • Penicillin G benzathine 2.4 million units IM as a single dose 1

Late Latent Syphilis or Unknown Duration (>1 year):

  • Penicillin G benzathine 2.4 million units IM weekly for 3 consecutive weeks 1

Neurosyphilis, Ocular, or Otic Syphilis:

  • Aqueous crystalline penicillin G 18-24 million units IV daily (administered as 3-4 million units IV every 4 hours or continuous infusion) for 10-14 days 1

Key Clinical Points:

  • Penicillin remains the only proven effective treatment for syphilis 9
  • Thorough evaluation for neurologic, ophthalmic, and otic symptoms is essential at any stage 1
  • These complications can occur at any stage and require IV penicillin therapy 1

Screening Recommendations:

  • Screen all pregnant women three times: first prenatal visit, third trimester, and at delivery 10
  • Screen persons living in counties with primary/secondary syphilis rates >4.6 per 100,000 (Healthy People 2030 threshold) 10

Penicillin Allergy:

  • Desensitization is required for pregnant women 3
  • Alternative regimens exist for non-pregnant patients but are less well-studied 3

Trichomoniasis (Trichomonas vaginalis)

Recommended First-Line Treatment:

  • Metronidazole 500 mg orally twice daily for 7 days 1
  • Alternative: Metronidazole 2 g orally as a single dose 7
  • Alternative: Tinidazole 2 g orally as a single dose 7

Key Clinical Points:

  • The 7-day metronidazole regimen is now preferred over single-dose therapy 1
  • Approximately 70% of trichomoniasis infections are asymptomatic 8
  • Patients should abstain from alcohol during treatment and for 24 hours after metronidazole or 72 hours after tinidazole 7

Important Management:

  • Treat sexual partners simultaneously 7
  • If alcohol recently ingested or emergency contraception provided, can take medication at home rather than directly observed 7

Genital Herpes (HSV-1 and HSV-2)

First Clinical Episode:

  • Acyclovir 400 mg orally three times daily for 7-10 days 11
  • Valacyclovir 1 g orally twice daily for 7-10 days 11
  • Famciclovir 250 mg orally three times daily for 7-10 days 11

Recurrent Episodes:

  • Acyclovir 800 mg orally twice daily for 5 days 11
  • Valacyclovir 500 mg orally twice daily for 3 days 11
  • Famciclovir 1 g orally twice daily for 1 day 11

Suppressive Therapy (for frequent recurrences):

  • Acyclovir 400 mg orally twice daily 11
  • Valacyclovir 500-1000 mg orally once daily 11
  • Famciclovir 250 mg orally twice daily 11

Key Clinical Points:

  • No cure is available for genital herpes 8
  • Early initiation of therapy reduces duration of illness and may prevent complications including urinary retention, meningism, or severe systemic illness 11
  • Rates of HSV-1 and HSV-2 have declined in the US from 1999-2016 8
  • Nucleic acid amplification tests have high sensitivity (86.1-100%) and specificity (97.1-100%) for symptomatic HSV 8

Genital Warts (HPV types 6 and 11)

Patient-Applied Treatments:

  • Imiquimod 5% cream applied once daily at bedtime, three times per week for up to 16 weeks 12
  • Podofilox 0.5% solution or gel applied twice daily for 3 days, followed by 4 days off therapy, repeated for up to 4 cycles 12
  • Sinecatechins 15% ointment (green tea extract catechins) applied three times daily for up to 16 weeks 12

Provider-Applied Treatments:

  • Cryotherapy with liquid nitrogen or cryoprobe, repeated every 1-2 weeks 2
  • Podophyllin resin 10-25% in compound tincture of benzoin, applied weekly 2
  • Trichloroacetic acid (TCA) 80-90% applied weekly 2
  • Surgical removal (excision, electrocautery, laser) 2

Key Clinical Points:

  • Sinecatechins is a newer patient-applied option added to 2010 CDC guidelines 12
  • No single treatment is ideal for all patients or all warts 2
  • Visible genital warts are usually caused by HPV types 6 or 11, which are not associated with cervical cancer 2
  • HPV vaccine (quadrivalent or bivalent) is recommended for prevention 12

Mycoplasma genitalium

Recommended Treatment:

  • Moxifloxacin 400 mg orally once daily for 7-14 days 9, 10
  • Alternative: Doxycycline 100 mg orally twice daily for 7 days followed by moxifloxacin 400 mg orally once daily for 7 days 10

Key Clinical Points:

  • High resistance to macrolides (azithromycin) limits treatment options 8, 9
  • Fluoroquinolones like moxifloxacin are increasingly required 8, 9
  • Testing and treatment guidance continues to evolve 10

Sexual Assault Prophylaxis

Recommended Empiric Regimen:

  • Ceftriaxone 250 mg IM single dose PLUS Azithromycin 1 g orally single dose PLUS Metronidazole 2 g orally single dose (or Tinidazole 2 g orally single dose) 7
  • Emergency contraception should be considered 7
  • Hepatitis B vaccination if not previously vaccinated 7
  • HPV vaccination for females aged 9-26 years and males aged 9-21 years (through age 26 for MSM) 7

Rationale:

  • Compliance with follow-up is poor among sexual assault survivors 7
  • Presumptive treatment covers chlamydia, gonorrhea, and trichomoniasis 7
  • If alcohol recently ingested, metronidazole/tinidazole can be taken at home to minimize side effects 7

References

Guideline

sexually transmitted diseases treatment guidelines, 2010.

MMWR Recommendations and Reports, 2010

Guideline

sexually transmitted diseases treatment guidelines, 2006.

MMWR Recommendations and Reports, 2006

Guideline

sexually transmitted diseases treatment guidelines, 2015.

MMWR Recommendations and Reports, 2015

Research

[Antibiotic treatment for sexually transmitted infections].

Dermatologie (Heidelberg, Germany), 2025

Research

Clinical Updates in Sexually Transmitted Infections, 2024.

Journal of women's health (2002), 2024

Research

2024 European guidelines for the management of genital herpes.

Journal of the European Academy of Dermatology and Venereology : JEADV, 2024

Research

Updates on human papillomavirus and genital warts and counseling messages from the 2010 Sexually Transmitted Diseases Treatment Guidelines.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2011

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.